No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ABOS Acumen Pharmaceuticals
- 1.850
- +0.050+2.78%
Close Dec 20 16:00 ET
- 1.900
- +0.050+2.70%
Post 19:32 ET
111.15MMarket Cap-1.34P/E (TTM)
1.860High1.750Low995.50KVolume1.780Open1.800Pre Close1.82MTurnover3.07%Turnover RatioLossP/E (Static)60.08MShares5.09052wk High0.51P/B59.97MFloat Cap1.71552wk Low--Dividend TTM32.42MShs Float26.980Historical High--Div YieldTTM6.11%Amplitude1.715Historical Low1.823Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Does Acumen Pharmaceuticals (NASDAQ:ABOS) Have A Healthy Balance Sheet?
BofA Securities Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating
Express News | Acumen Pharmaceuticals Inc : BofA Global Research Cuts Price Objective to $12 From $14
H.C. Wainwright Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating, Maintains Target Price $15
Acumen Pharmaceuticals Advances Alzheimer's Therapeutic
Heat List
US
Overall
Symbol
Price
% Chg
No Data